In the last trading session, 2.72 million shares of the Applied Dna Sciences Inc (NASDAQ:APDN) were traded, and its beta was 0.37. Most recently the company’s share price was $0.18, and it changed around -$0.01 or -5.96% from the last close, which brings the market valuation of the company to $9.93M. APDN currently trades at a discount to its 52-week high of $14.40, offering almost -7900.0% off that amount. The share price’s 52-week low was $0.12, which indicates that the current value has risen by an impressive 33.33% since then. We note from Applied Dna Sciences Inc’s average daily trading volume that its 10-day average is 3.56 million shares, with the 3-month average coming to 6.19 million.
Applied Dna Sciences Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended APDN as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Applied Dna Sciences Inc is expected to report earnings per share of -0.33 for the current quarter.
Applied Dna Sciences Inc (NASDAQ:APDN) trade information
Instantly APDN has showed a red trend with a performance of -5.96% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.2029 on recent trading dayincreased the stock’s daily price by 11.29%. The company’s shares are currently down -11.76% year-to-date, but still down -6.93% over the last five days. On the other hand, Applied Dna Sciences Inc (NASDAQ:APDN) is -21.74% down in the 30-day period. We can see from the shorts that 1.77 million shares have been sold at a short interest cover period of 0.47 day(s).
The consensus price target as assigned by Wall Street analysts is $1.5, which translates to bulls needing to increase their stock price by 88.0% from its current value. Analyst projections state that APDN is forecast to be at a low of $1.5 and a high of $1.5.
Applied Dna Sciences Inc (APDN) estimates and forecasts
Applied Dna Sciences Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -55.37 percent over the past six months and at a 52.20% annual growth rate that is well above the industry average of 14.80%. The year-over-year growth rate is expected to be 51.67%, up from the previous year.
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of 1.18M in revenue for the current quarter. 1 analysts expect Applied Dna Sciences Inc to make 1.3M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 891.16k and 929.63k respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 31.85%. Forecasts for the next quarter put sales growth at 40.16%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 60.68%.
APDN Dividends
Applied Dna Sciences Inc’s next quarterly earnings report is expected to be released in February.
Applied Dna Sciences Inc (NASDAQ:APDN)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 20.98% of Applied Dna Sciences Inc shares, and 25.01% of them are in the hands of institutional investors. The stock currently has a share float of 31.66%. Applied Dna Sciences Inc stock is held by 26.0 institutions, with MATHER GROUP, LLC. being the largest institutional investor. By 2024-06-30, it held 0.0803% of the shares, which is about 700.0 shares worth $287.0.
Fidelity Extended Market Index Fund and Fidelity Total Market Index Fund were the top two Mutual Funds as of Nov 30, 2024 . The former held 57.64 shares worth $10375.0, making up 0.10% of all outstanding shares. On the other hand, Fidelity Total Market Index Fund held roughly 26.01 shares worth around $4682.0, which represents about 0.05% of the total shares outstanding.
